The following table presents reportable segment loss, including significant expenses regularly provided to the CODM, attributable to the Company’s reportable segment for the three and six months ended June 30, 2025 and 2024 (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Revenue	$	114,449	$	54,116	$	196,180	$	95,490
Less:
Cost of goods sold	1,521		2,061		6,201		3,565
Research and development:
External research and development	27,461		31,944		49,816		57,856
Internal personnel costs	18,215		17,949		38,317		37,695
Other research and development	3,686		4,437		8,118		8,199
Total research and development	49,362		54,330		96,251		103,750
Selling, general and administrative	76,216		64,776		149,055		128,999
In-process research and development	—		—		—		65,205
Restructuring	—		653		—		912
Total other (expense) income, net	(85)		(1,863)		1,405		1,607
Income tax provision on continuing operations	(20)		(85)		(59)		(276)
Loss from discontinued operations, net of tax	—		(757)		—		(860)
Net loss	$	(12,755)	$	(70,409)	$	(53,981)	$	(206,470)